Literature DB >> 8841443

Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry.

S M Kipriyanov1, O A Kupriyanova, M Little, G Moldenhauer.   

Abstract

Cloning the correct genes coding for antibody variable domains (especially VL kappa) from hybridomas is often complicated by the presence of several immunoglobulin transcripts, some of them arising from the myeloma cell line. Indeed, four different VL genes were obtained after the amplification of immunoglobulin genes by PCR from the hybridoma HD37, which produces an antibody against the human CD19 B cell differentiation antigen. Most of the variants (eight out of 15) were derived from the kappa chain of the myeloma MOPC-21. For the rapid functional evaluation of recombinant antibody fragments against cell surface antigens, we established an efficient expression and detection system. First, deleted and mutated genes were eliminated by a colony screening procedure. Bacteria from picked colonies were then induced and grown in the presence of 0.4 M sucrose to increase the accumulation of soluble scFv in the periplasm (5-10 micrograms per ml of bacterial shake-tube culture). Finally, the cell-specific binding of scFv in crude periplasmic extracts was detected by flow cytometry. This procedure facilitated the efficient cloning of a functional anti-CD19 VH/VL combination from the hybridoma cDNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841443     DOI: 10.1016/0022-1759(96)00115-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

Review 1.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

2.  Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL.

Authors:  Martin Felices; Behiye Kodal; Peter Hinderlie; Michael F Kaminski; Sarah Cooley; Daniel J Weisdorf; Daniel A Vallera; Jeffrey S Miller; Veronika Bachanova
Journal:  Blood Adv       Date:  2019-03-26

3.  Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.

Authors:  Adalbert Krawczyk; Jürgen Krauss; Anna M Eis-Hübinger; Martin P Däumer; Robert Schwarzenbacher; Ulf Dittmer; Karl E Schneweis; Dirk Jäger; Michael Roggendorf; Michaela A E Arndt
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody.

Authors:  M Welschof; P Terness; S M Kipriyanov; D Stanescu; F Breitling; H Dörsam; S Dübel; M Little; G Opelz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours.

Authors:  Matthias Eder; Stefan Knackmuss; Fabrice Le Gall; Uwe Reusch; Vladimir Rybin; Melvyn Little; Uwe Haberkorn; Walter Mier; Michael Eisenhut
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-16       Impact factor: 9.236

6.  Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy.

Authors:  Daniel A Vallera; Hua Chen; Andrew R Sicheneder; Angela Panoskaltsis-Mortari; Elizabeth P Taras
Journal:  Leuk Res       Date:  2009-03-26       Impact factor: 3.156

7.  Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.

Authors:  Matthias Eder; Björn Wängler; Stefan Knackmuss; Fabrice LeGall; Melvyn Little; Uwe Haberkorn; Walter Mier; Michael Eisenhut
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-29       Impact factor: 9.236

8.  Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme.

Authors:  J Krauss; M A E Arndt; Z Zhu; D L Newton; B K Vu; V Choudhry; R Darbha; X Ji; N S Courtenay-Luck; M P Deonarain; J Richards; S M Rybak
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

9.  CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice.

Authors:  Perry Tsai; William O Thayer; Liqin Liu; Guido Silvestri; Jeffrey L Nordstrom; J Victor Garcia
Journal:  Mol Ther Oncolytics       Date:  2016-03-02       Impact factor: 7.200

10.  A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors.

Authors:  Julius W Kim; Jacob S Young; Elena Solomaha; Deepak Kanojia; Maciej S Lesniak; Irina V Balyasnikova
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.